Koronis Pharmaceuticals, Inc.

Redmond, WA 98052

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $203K
First Award Date 08/01/02
Most Recent Award Date 08/01/02

Key Personnel

Last Name Name Awards Contact
Daifuku Richard Daifuku 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Budget: 08/01/02 - 04/30/03

DESCRIPTION (provided by applicant): Research carried out at the University of Washington has demonstrated the feasibility of using a novel class of deoxynbonucleoside analogs to drive the mutation rate of HIV over the threshold for viral viability with minimal toxicity to host cells, a process termed "lethal mutagenesis" or more recently "selec...